Consequently, H3Rs appear to be an attractive target for the design of new H3R antagonists suitable for the treatment of many neuropsychiatric diseases, including epilepsy [20,21,22,23,24,25,26,27]. This evidence concerns the gene HRH3 and epilepsy.